From None: 2025-04-25 14:13:00

Integer Holdings Corporation, trading as NYSE:ITGR, excels in medical device manufacturing, serving diverse healthcare sectors. Truist Financial’s $150 price target for ITGR implies a 23.47% upside from the stock’s price of $121.49. In Q1 2025, ITGR reported a 14.9% increase in adjusted EPS to $1.31, exceeding estimates by 3.2%. Revenues hit $437.4 million, growing 7.3% year-over-year, surpassing estimates by 1.3%. Organic revenue growth of 6.3% was driven by new products, acquisitions, and operational efficiency, positioning ITGR for continued success.



Read more at None:: Integer Holdings Corporation’s Financial Performan…